Private Market View

Nimbus Therapeutics

Drug Discovery

Last price · $/share
Implied valuation
Total raised
$335.0M
Last round
Later Stage VC (Series E)
Aug 2023
Team — not yet on record

No current team members for Nimbus Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
  • ·Post-money valuations for all 2 rounds
  • ·Watchlist + deal alerts for Nimbus Therapeutics
Create free account
No card required